glp 1 commercial hers TV Spot, 'GLP-1 Injections' LifeMD TV Spot, 'Helping People

Even light resistance can increase your resting metabolic rate by 5-7%, keeping weight regain at bay

Here's what we'll cover Key takeaways Semaglutide is a weekly injectable medication for type 2 diabetes, obesity, and some forms of heart disease, administered subcutaneously in the stomach, thigh, or upper arm

Tailored impact of dietary fibers on gut microbiota: A multi-omics comparison on the lean and obese microbial communities

GLP-1s and Addiction The authors of GLP-1 Therapeutics and Their Emerging Role in Alcohol and Substance Use Disorders: An Endocrinology Primer , appearing in October 2025 in JES, point out that the World Health Organization reported 890 million adults and 60 million children and adolescents had obesity in 2022 globally

Cumulative Effect Over Time Sometimes, a rash might develop not immediately but after prolonged use of semaglutide

Still useful in a multi-lever approach because it is inexpensive and has a long safety record (with appropriate monitoring and contraindications respected)